AN2 Therapeutics Inc (ANTX) Form 4 Filed on July 10

AN2 Therapeutics Inc (ANTX) filed a Form 4 on July 10, detailing insider transactions. The report indicated changes in ownership for certain executives, providing transparency into the company's stock holdings. This type of filing can affect investor confidence as it reveals how insiders are managing their stakes in the company. The details of these transactions are important for investors monitoring insider activity as it might influence market perceptions of ANTX.